Companion Diagnostics Market Research Report 2019, Business Size, Segment by Type, Regions and End User, Trend Analysis

The global companion diagnostics market is forecasted to grow at a rate of 18.9% in terms of value, from USD 2.43 billion in 2019 to reach USD 9.72 billion by 2027.

Expanding government funding and raising awareness of the benefits of early diagnosis will escalate the percentage of diagnostic procedures. Such labs will have a disease-specific diagnosis for many forms of cancers that will fuel development in the market. Testing laboratories integrate technically advanced instruments that produce successful performance. Owing to high disposable income and the provision of existing health-care services, North America controlled the sector. Sturdy study efforts aimed at improving new medications and treatments will boost competition on the market for national diagnostics companions.

The report titled “Global Companion Diagnostics Market Forecast to 2027” offered by Emergen Research offers a bird's eye view of the market to present a projected growth rate of the industry in the coming years. The research report is an investigative study of the Companion Diagnostics market that offers crucial information pertaining to the market size and market share of the sector on a global scale. The research study presents an industry-wide summary of the Companion Diagnostics market, including drivers, constraints, technological advancements, product developments, limitations, growth strategies, growth prospects, etc. among others. The report analyzes the market based on different categories, such as product types, end-user applications, and leading geographical regions.

Revenue and cost profit analysis of major player dominating the Companion Diagnostics market:

The in-depth report on the Companion Diagnostics market, along with details on import / export, consumption and production rate, demand and supply dynamics, competitive landscape benchmarking, market share, and other key elements, strives to offer the reader a complete crystal clear understanding of the Companion Diagnostics business sphere. The individual in-depth study of the prominent players of the market offers insights into their market position, geographical presence, production and manufacturing capacity, gross margin, revenue generation, and business expansion strategies.

Key participants include Agilent Technologies, Foundation Medicine, Myriad Genetic Laboratories, Thermo Fisher Scientific, Johnson Johnson, Arup Laboratories, Abbott, MolecularMD, BioMérieux, and Illumina, among others.

To know more about the report, visit:

Thank you for reading our report. For further information or queries regarding the report or its customization, please connect with us. Our team will ensure you get a report well-suited to your needs.


37 Blog Mensajes